These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

502 related items for PubMed ID: 21175241

  • 1. Optimal management of patients with non-small cell lung cancer and epidermal growth factor receptor mutations.
    Lin CC, Yang JC.
    Drugs; 2011 Jan 01; 71(1):79-88. PubMed ID: 21175241
    [Abstract] [Full Text] [Related]

  • 2. First-line treatment of advanced epidermal growth factor receptor (EGFR) mutation positive non-squamous non-small cell lung cancer.
    Greenhalgh J, Dwan K, Boland A, Bates V, Vecchio F, Dundar Y, Jain P, Green JA.
    Cochrane Database Syst Rev; 2016 May 25; (5):CD010383. PubMed ID: 27223332
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Which tyrosine kinase inhibitor should be recommended as initial treatment for non-small cell lung cancer patients with EGFR mutations?
    Tartarone A, Lerose R, Lazzari C, Gregorc V, Aieta M.
    Med Oncol; 2014 Aug 25; 31(8):78. PubMed ID: 24958518
    [Abstract] [Full Text] [Related]

  • 8. Different treatment orders achieved similar clinical results: a retrospective study for retreatment of epidermal growth factor receptor tyrosine kinase inhibitors in 120 patients with non-small-cell lung cancer.
    Tang C, Gao H, Li X, Liu Y, Li J, Qin H, Wang W, Qu L, An J, Yang S, Liu X.
    J Cancer Res Clin Oncol; 2014 Mar 25; 140(3):427-33. PubMed ID: 24401995
    [Abstract] [Full Text] [Related]

  • 9. Epidermal growth factor receptor tyrosine kinase inhibitors as first-line treatment in advanced nonsmall-cell lung cancer.
    Rosell R, Viteri S, Molina MA, Benlloch S, Taron M.
    Curr Opin Oncol; 2010 Mar 25; 22(2):112-20. PubMed ID: 19949333
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [The predictive value of EGFR status in non-small cell lung cancer patients treated with EGFR-TKIs].
    Wang Y, Liu H, Chen J.
    Zhongguo Fei Ai Za Zhi; 2010 Apr 25; 13(4):375-9. PubMed ID: 20677568
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Primary resistance to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) in patients with non-small-cell lung cancer harboring TKI-sensitive EGFR mutations: an exploratory study.
    Lee JK, Shin JY, Kim S, Lee S, Park C, Kim JY, Koh Y, Keam B, Min HS, Kim TM, Jeon YK, Kim DW, Chung DH, Heo DS, Lee SH, Kim JI.
    Ann Oncol; 2013 Aug 25; 24(8):2080-7. PubMed ID: 23559152
    [Abstract] [Full Text] [Related]

  • 17. Non-small cell lung cancer harbouring non-resistant uncommon EGFR mutations: Mutation patterns, effectiveness of epidermal growth factor receptor-tyrosine kinase inhibitors and prognostic factors.
    Chang LC, Lim CK, Chang LY, Chen KY, Shih JY, Yu CJ.
    Eur J Cancer; 2019 Sep 25; 119():77-86. PubMed ID: 31425965
    [Abstract] [Full Text] [Related]

  • 18. Activating and resistance mutations of EGFR in non-small-cell lung cancer: role in clinical response to EGFR tyrosine kinase inhibitors.
    Gazdar AF.
    Oncogene; 2009 Aug 25; 28 Suppl 1(Suppl 1):S24-31. PubMed ID: 19680293
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of the epidermal growth factor receptor in combined modality treatment for locally advanced non-small cell lung cancer.
    Ready N.
    Semin Oncol; 2005 Apr 25; 32(2 Suppl 3):S35-41. PubMed ID: 16015534
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.